000717229 000__ 04066cam\a2200445Ii\4500
000717229 001__ 717229
000717229 005__ 20230306140201.0
000717229 006__ m\\\\\o\\d\\\\\\\\
000717229 007__ cr\cn\nnnunnun
000717229 008__ 141224s2014\\\\enka\\\\ob\\\\001\0\eng\d
000717229 020__ $$a9781447165361$$qelectronic book
000717229 020__ $$a1447165365$$qelectronic book
000717229 020__ $$z9781447165354
000717229 0247_ $$a10.1007/978-1-4471-6536-1$$2doi
000717229 035__ $$aSP(OCoLC)ocn898733011
000717229 035__ $$a717229
000717229 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dYDXCP$$dCOO
000717229 049__ $$aISEA
000717229 050_4 $$aRM345
000717229 08204 $$a615.7/042$$223
000717229 1001_ $$aOzkaya, Esen,$$eauthor.
000717229 24510 $$aAdverse cutaneous drug reactions to cardiovascular drugs$$h[electronic resource] /$$cEsen Özkaya, Kurtuluş Didem Yazganoğlu.
000717229 264_1 $$aLondon :$$bSpringer,$$c2014.
000717229 300__ $$a1 online resource (xxi, 259 pages) :$$bcolor illustrations
000717229 336__ $$atext$$btxt$$2rdacontent
000717229 337__ $$acomputer$$bc$$2rdamedia
000717229 338__ $$aonline resource$$bcr$$2rdacarrier
000717229 504__ $$aIncludes bibliographical references and index.
000717229 5050_ $$aIntroduction (General information on different types of ACDR) -- Angiotensin converting enzyme inhibitors -- Angiotensin II receptor blockers -- Alpha-2 adrenergic receptor agonists -- Alpha-adrenergic receptor blockers -- Adrenergic neuron blockers -- Class I antiarrhythmic drugs (sodium channel blockers) -- Beta adrenergic receptor blockers (class II antiarrhythmics) -- Class III antiarrhythmics -- Calcium channel blockers (class IV antiarrhythmics) -- Diuretics -- Sympathomimetics -- Vasodilatory drugs -- Lipid lowering drugs -- Platelet inhibitors -- Thrombolytics -- Anticoagulants -- Miscellaneous drugs -- Diagnostic procedure: The role of patch. .
000717229 506__ $$aAccess limited to authorized users.
000717229 520__ $$aThis book describes adverse cutaneous drug reactions as among the most frequent events in patients receiving drug therapy. Cardiovascular drugs are an important group as there are a greater number of indications for the use of new drugs and their prescription continues to increase. The exact incidence of cutaneous side effects from cardiovascular drugs is difficult to estimate due to sporadic reporting. Moreover, a reliable connection between a certain drug and a certain type of reaction can only rarely be made, aside from the well-known angioedema/urticaria from angiotensin-converting enzyme inhibitors, lichen planus/lichenoid reaction from beta adrenergic blockers, and photosensitivity from thiazid diuretics. These reactions can extend to rare but life-threatening conditions such as erythroderma, Stevens-Johnson syndrome, toxic epidermal necrolysis and drug hypersensitivity syndrome. Adverse Cutaneous Drug Reactions To Cardiovascular Drugs reviews the reported types of reactions to cardiovascular drugs. Each is discussed according to drug class and the type of dermatologic reaction with special emphasize on cross-reactions and the role of patch testing in diagnosis. A total of 116 images are included featuring clinical appearance of common adverse cutaneous drug reactions and diagnostic procedures such as patch and photopatch testing with the suspected drugs. Complementary tables may allow to scan the most common cutaneous reactions and the related cardiovascular drugs along with the possible cross reactions at first glance. It will thus be of considerable importance to all dermatologists and medical professionals who manage the skin, while being an important reference resource for cardiologists in terms of identifying potential adverse reactions to the drugs they prescribe.
000717229 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 24, 2014).
000717229 650_0 $$aCardiovascular agents$$xSide effects.
000717229 650_0 $$aDermatopharmacology.
000717229 7001_ $$aYazganoglu, K. Didem,$$eauthor.
000717229 77608 $$iPrint version:$$z9781447165354
000717229 85280 $$bebk$$hSpringerLink
000717229 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://dx.doi.org/10.1007/978-1-4471-6536-1$$zOnline Access
000717229 909CO $$ooai:library.usi.edu:717229$$pGLOBAL_SET
000717229 980__ $$aEBOOK
000717229 980__ $$aBIB
000717229 982__ $$aEbook
000717229 983__ $$aOnline
000717229 994__ $$a92$$bISE